Dunhill Financial »

Allogene Therapeutics shares owned by Dunhill Financial

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Dunhill Financial from 13F filings

Historical chart of Dunhill Financial investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Dunhill Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Dunhill Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $225 70 3.21

More positions owned by Dunhill Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Kld400 Soc (DSI)
Ishares Tr Esg Aw Msci Eafe (ESGD)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
First Tr Exchange-traded Buywrit Incm Etf (FTHI)
Apple (AAPL)
Vanguard Index Fds Small Cp Etf (VB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
First Tr Exch Trd Alphdx Europe Alphadex (FEP)
Ishares Tr Russell 3000 Etf (IWV)
Ishares Tr Esg Aware Msci (ESML)
Mastercard Incorporated Cl A (MA)
First Tr Exchange Traded Nasdq Cln Edge (GRID)

View all positions for Dunhill Financial

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Caxton Associates
Nordea Investment Management Ab
Charles Schwab Investment Management

View all funds holding Allogene Therapeutics